Use of Polymyxin B Hemoperfusion in a Patient with Septic Shock and Septic Cardiomyopathy Who Was Placed on Extracorporeal Membrane Oxygen Support
Korean Journal of Critical Care Medicine. 2016;31(2):123 
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial
Yearbook of Medicine. 2009;2009:105-107
Successful use of extracorporeal membrane oxygenation support in severe septic shock with associated acute cardiomyopathy
Journal of Cardiac Surgery. 2018;33(1):50-52
Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
Critical Care. 2012;16(S3):
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial
Yearbook of Critical Care Medicine. 2010;2010:214-216
Clinical Effects of Polymyxin B Hemoperfusion in Patients With Septic Shock Caused by Urinary Tract Infection
Therapeutic Apheresis and Dialysis. 2018;23(1):80-85
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial
Yearbook of Critical Care Medicine. 2010;2010:267-269
FP173THE DURATION FROM RECOGNITION OF SHOCK TO THE INDUCTION OF THE DIRECT HEMOPERFUSION OF POLYMYXIN B-IMMOBILIZED FIBER CRITICALLY DETERMINES THE SURVIVAL OF PATIENT WITH SEPTIC SHOCK
Nephrology Dialysis Transplantation. 2019;34(Supplement_1):
Treatment of Pyonephritis Complicated by Septic Shock Using Extracorporeal Device Polymyxin B-Hemoperfusion
Blood Purification. 2020;49(5):627-630
Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
Critical Care. 2011;15(S1):